ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Janus Kinase inhibitors (JAKi) Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-35D17398
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Janus Kinase inhibitors JAKi Market Research Report 2024
BUY CHAPTERS

Global Janus Kinase inhibitors (JAKi) Market Research Report 2024

Code: QYRE-Auto-35D17398
Report
June 2024
Pages:67
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
JANUS
Eli Lilly and Co
Pfizer Inc
AbbVie
Galapagos

Janus Kinase inhibitors (JAKi) Market

Janus Kinase Inhibitors (JAKi for short) are a class of targeted small molecule drugs that inhibit immune and inflammatory responses by inhibiting the activity of Janus kinase (JAK) and blocking intracellular signal transduction pathways. JAK kinase is an important enzyme involved in signaling of multiple cytokines, and JAKi has shown significant efficacy in the treatment of a variety of autoimmune and inflammatory diseases.
The global Janus Kinase inhibitors (JAKi) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Janus Kinase inhibitors (JAKi) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Janus Kinase inhibitors (JAKi) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Janus Kinase inhibitors (JAKi) include Eli Lilly and Co., Pfizer Inc., AbbVie, Galapagos NV, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Janus Kinase inhibitors (JAKi), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Janus Kinase inhibitors (JAKi).
The Janus Kinase inhibitors (JAKi) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Janus Kinase inhibitors (JAKi) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Janus Kinase inhibitors (JAKi) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Janus Kinase inhibitors (JAKi) Market Report

Report Metric Details
Report Name Janus Kinase inhibitors (JAKi) Market
Segment by Type
  • Tofacitinib
  • Abrocitinib
  • Baricitinib
  • Upadacitinib
  • Filgotinib
Segment by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Eli Lilly and Co., Pfizer Inc., AbbVie, Galapagos NV
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Janus Kinase inhibitors (JAKi) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Janus Kinase inhibitors (JAKi) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Janus Kinase inhibitors (JAKi) Market report?

Ans: The main players in the Janus Kinase inhibitors (JAKi) Market are Eli Lilly and Co., Pfizer Inc., AbbVie, Galapagos NV

What are the Application segmentation covered in the Janus Kinase inhibitors (JAKi) Market report?

Ans: The Applications covered in the Janus Kinase inhibitors (JAKi) Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Janus Kinase inhibitors (JAKi) Market report?

Ans: The Types covered in the Janus Kinase inhibitors (JAKi) Market report are Tofacitinib, Abrocitinib, Baricitinib, Upadacitinib, Filgotinib

1 Janus Kinase inhibitors (JAKi) Market Overview
1.1 Product Definition
1.2 Janus Kinase inhibitors (JAKi) by Type
1.2.1 Global Janus Kinase inhibitors (JAKi) Market Value Comparison by Type (2024-2030)
1.2.2 Tofacitinib
1.2.3 Abrocitinib
1.2.4 Baricitinib
1.2.5 Upadacitinib
1.2.6 Filgotinib
1.3 Janus Kinase inhibitors (JAKi) by Application
1.3.1 Global Janus Kinase inhibitors (JAKi) Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Janus Kinase inhibitors (JAKi) Market Size Estimates and Forecasts
1.4.1 Global Janus Kinase inhibitors (JAKi) Revenue 2019-2030
1.4.2 Global Janus Kinase inhibitors (JAKi) Sales 2019-2030
1.4.3 Global Janus Kinase inhibitors (JAKi) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Janus Kinase inhibitors (JAKi) Market Competition by Manufacturers
2.1 Global Janus Kinase inhibitors (JAKi) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Janus Kinase inhibitors (JAKi) Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Janus Kinase inhibitors (JAKi), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Janus Kinase inhibitors (JAKi), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Janus Kinase inhibitors (JAKi), Product Type & Application
2.7 Global Key Manufacturers of Janus Kinase inhibitors (JAKi), Date of Enter into This Industry
2.8 Global Janus Kinase inhibitors (JAKi) Market Competitive Situation and Trends
2.8.1 Global Janus Kinase inhibitors (JAKi) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Janus Kinase inhibitors (JAKi) Players Market Share by Revenue
2.8.3 Global Janus Kinase inhibitors (JAKi) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Janus Kinase inhibitors (JAKi) Market Scenario by Region
3.1 Global Janus Kinase inhibitors (JAKi) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Janus Kinase inhibitors (JAKi) Sales by Region: 2019-2030
3.2.1 Global Janus Kinase inhibitors (JAKi) Sales by Region: 2019-2024
3.2.2 Global Janus Kinase inhibitors (JAKi) Sales by Region: 2025-2030
3.3 Global Janus Kinase inhibitors (JAKi) Revenue by Region: 2019-2030
3.3.1 Global Janus Kinase inhibitors (JAKi) Revenue by Region: 2019-2024
3.3.2 Global Janus Kinase inhibitors (JAKi) Revenue by Region: 2025-2030
3.4 North America Janus Kinase inhibitors (JAKi) Market Facts & Figures by Country
3.4.1 North America Janus Kinase inhibitors (JAKi) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Janus Kinase inhibitors (JAKi) Sales by Country (2019-2030)
3.4.3 North America Janus Kinase inhibitors (JAKi) Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Janus Kinase inhibitors (JAKi) Market Facts & Figures by Country
3.5.1 Europe Janus Kinase inhibitors (JAKi) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Janus Kinase inhibitors (JAKi) Sales by Country (2019-2030)
3.5.3 Europe Janus Kinase inhibitors (JAKi) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Janus Kinase inhibitors (JAKi) Market Facts & Figures by Region
3.6.1 Asia Pacific Janus Kinase inhibitors (JAKi) Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Janus Kinase inhibitors (JAKi) Sales by Region (2019-2030)
3.6.3 Asia Pacific Janus Kinase inhibitors (JAKi) Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Janus Kinase inhibitors (JAKi) Market Facts & Figures by Country
3.7.1 Latin America Janus Kinase inhibitors (JAKi) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Janus Kinase inhibitors (JAKi) Sales by Country (2019-2030)
3.7.3 Latin America Janus Kinase inhibitors (JAKi) Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Janus Kinase inhibitors (JAKi) Market Facts & Figures by Country
3.8.1 Middle East and Africa Janus Kinase inhibitors (JAKi) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Janus Kinase inhibitors (JAKi) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Janus Kinase inhibitors (JAKi) Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Janus Kinase inhibitors (JAKi) Sales by Type (2019-2030)
4.1.1 Global Janus Kinase inhibitors (JAKi) Sales by Type (2019-2024)
4.1.2 Global Janus Kinase inhibitors (JAKi) Sales by Type (2025-2030)
4.1.3 Global Janus Kinase inhibitors (JAKi) Sales Market Share by Type (2019-2030)
4.2 Global Janus Kinase inhibitors (JAKi) Revenue by Type (2019-2030)
4.2.1 Global Janus Kinase inhibitors (JAKi) Revenue by Type (2019-2024)
4.2.2 Global Janus Kinase inhibitors (JAKi) Revenue by Type (2025-2030)
4.2.3 Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Type (2019-2030)
4.3 Global Janus Kinase inhibitors (JAKi) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Janus Kinase inhibitors (JAKi) Sales by Application (2019-2030)
5.1.1 Global Janus Kinase inhibitors (JAKi) Sales by Application (2019-2024)
5.1.2 Global Janus Kinase inhibitors (JAKi) Sales by Application (2025-2030)
5.1.3 Global Janus Kinase inhibitors (JAKi) Sales Market Share by Application (2019-2030)
5.2 Global Janus Kinase inhibitors (JAKi) Revenue by Application (2019-2030)
5.2.1 Global Janus Kinase inhibitors (JAKi) Revenue by Application (2019-2024)
5.2.2 Global Janus Kinase inhibitors (JAKi) Revenue by Application (2025-2030)
5.2.3 Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Application (2019-2030)
5.3 Global Janus Kinase inhibitors (JAKi) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Eli Lilly and Co.
6.1.1 Eli Lilly and Co. Company Information
6.1.2 Eli Lilly and Co. Description and Business Overview
6.1.3 Eli Lilly and Co. Janus Kinase inhibitors (JAKi) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Eli Lilly and Co. Janus Kinase inhibitors (JAKi) Product Portfolio
6.1.5 Eli Lilly and Co. Recent Developments/Updates
6.2 Pfizer Inc.
6.2.1 Pfizer Inc. Company Information
6.2.2 Pfizer Inc. Description and Business Overview
6.2.3 Pfizer Inc. Janus Kinase inhibitors (JAKi) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Inc. Janus Kinase inhibitors (JAKi) Product Portfolio
6.2.5 Pfizer Inc. Recent Developments/Updates
6.3 AbbVie
6.3.1 AbbVie Company Information
6.3.2 AbbVie Description and Business Overview
6.3.3 AbbVie Janus Kinase inhibitors (JAKi) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 AbbVie Janus Kinase inhibitors (JAKi) Product Portfolio
6.3.5 AbbVie Recent Developments/Updates
6.4 Galapagos NV
6.4.1 Galapagos NV Company Information
6.4.2 Galapagos NV Description and Business Overview
6.4.3 Galapagos NV Janus Kinase inhibitors (JAKi) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Galapagos NV Janus Kinase inhibitors (JAKi) Product Portfolio
6.4.5 Galapagos NV Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Janus Kinase inhibitors (JAKi) Industry Chain Analysis
7.2 Janus Kinase inhibitors (JAKi) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Janus Kinase inhibitors (JAKi) Production Mode & Process
7.4 Janus Kinase inhibitors (JAKi) Sales and Marketing
7.4.1 Janus Kinase inhibitors (JAKi) Sales Channels
7.4.2 Janus Kinase inhibitors (JAKi) Distributors
7.5 Janus Kinase inhibitors (JAKi) Customers
8 Janus Kinase inhibitors (JAKi) Market Dynamics
8.1 Janus Kinase inhibitors (JAKi) Industry Trends
8.2 Janus Kinase inhibitors (JAKi) Market Drivers
8.3 Janus Kinase inhibitors (JAKi) Market Challenges
8.4 Janus Kinase inhibitors (JAKi) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
JANUS
Eli Lilly and Co
Pfizer Inc
AbbVie
Galapagos
List of Tables
 Table 1. Global Janus Kinase inhibitors (JAKi) Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Janus Kinase inhibitors (JAKi) Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Janus Kinase inhibitors (JAKi) Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Janus Kinase inhibitors (JAKi) Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Janus Kinase inhibitors (JAKi) Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Janus Kinase inhibitors (JAKi) Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Janus Kinase inhibitors (JAKi) Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Janus Kinase inhibitors (JAKi) Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Janus Kinase inhibitors (JAKi), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Janus Kinase inhibitors (JAKi), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Janus Kinase inhibitors (JAKi), Product Type & Application
 Table 12. Global Key Manufacturers of Janus Kinase inhibitors (JAKi), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Janus Kinase inhibitors (JAKi) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Janus Kinase inhibitors (JAKi) as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Janus Kinase inhibitors (JAKi) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Janus Kinase inhibitors (JAKi) Sales by Region (2019-2024) & (K Units)
 Table 18. Global Janus Kinase inhibitors (JAKi) Sales Market Share by Region (2019-2024)
 Table 19. Global Janus Kinase inhibitors (JAKi) Sales by Region (2025-2030) & (K Units)
 Table 20. Global Janus Kinase inhibitors (JAKi) Sales Market Share by Region (2025-2030)
 Table 21. Global Janus Kinase inhibitors (JAKi) Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Region (2019-2024)
 Table 23. Global Janus Kinase inhibitors (JAKi) Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Region (2025-2030)
 Table 25. North America Janus Kinase inhibitors (JAKi) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Janus Kinase inhibitors (JAKi) Sales by Country (2019-2024) & (K Units)
 Table 27. North America Janus Kinase inhibitors (JAKi) Sales by Country (2025-2030) & (K Units)
 Table 28. North America Janus Kinase inhibitors (JAKi) Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Janus Kinase inhibitors (JAKi) Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Janus Kinase inhibitors (JAKi) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Janus Kinase inhibitors (JAKi) Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Janus Kinase inhibitors (JAKi) Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Janus Kinase inhibitors (JAKi) Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Janus Kinase inhibitors (JAKi) Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Janus Kinase inhibitors (JAKi) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Janus Kinase inhibitors (JAKi) Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Janus Kinase inhibitors (JAKi) Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Janus Kinase inhibitors (JAKi) Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Janus Kinase inhibitors (JAKi) Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Janus Kinase inhibitors (JAKi) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Janus Kinase inhibitors (JAKi) Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Janus Kinase inhibitors (JAKi) Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Janus Kinase inhibitors (JAKi) Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Janus Kinase inhibitors (JAKi) Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Janus Kinase inhibitors (JAKi) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Janus Kinase inhibitors (JAKi) Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Janus Kinase inhibitors (JAKi) Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Janus Kinase inhibitors (JAKi) Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Janus Kinase inhibitors (JAKi) Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Janus Kinase inhibitors (JAKi) Sales (K Units) by Type (2019-2024)
 Table 51. Global Janus Kinase inhibitors (JAKi) Sales (K Units) by Type (2025-2030)
 Table 52. Global Janus Kinase inhibitors (JAKi) Sales Market Share by Type (2019-2024)
 Table 53. Global Janus Kinase inhibitors (JAKi) Sales Market Share by Type (2025-2030)
 Table 54. Global Janus Kinase inhibitors (JAKi) Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Janus Kinase inhibitors (JAKi) Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Type (2019-2024)
 Table 57. Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Type (2025-2030)
 Table 58. Global Janus Kinase inhibitors (JAKi) Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Janus Kinase inhibitors (JAKi) Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Janus Kinase inhibitors (JAKi) Sales (K Units) by Application (2019-2024)
 Table 61. Global Janus Kinase inhibitors (JAKi) Sales (K Units) by Application (2025-2030)
 Table 62. Global Janus Kinase inhibitors (JAKi) Sales Market Share by Application (2019-2024)
 Table 63. Global Janus Kinase inhibitors (JAKi) Sales Market Share by Application (2025-2030)
 Table 64. Global Janus Kinase inhibitors (JAKi) Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Janus Kinase inhibitors (JAKi) Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Application (2019-2024)
 Table 67. Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Application (2025-2030)
 Table 68. Global Janus Kinase inhibitors (JAKi) Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Janus Kinase inhibitors (JAKi) Price (US$/Unit) by Application (2025-2030)
 Table 70. Eli Lilly and Co. Company Information
 Table 71. Eli Lilly and Co. Description and Business Overview
 Table 72. Eli Lilly and Co. Janus Kinase inhibitors (JAKi) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Eli Lilly and Co. Janus Kinase inhibitors (JAKi) Product
 Table 74. Eli Lilly and Co. Recent Developments/Updates
 Table 75. Pfizer Inc. Company Information
 Table 76. Pfizer Inc. Description and Business Overview
 Table 77. Pfizer Inc. Janus Kinase inhibitors (JAKi) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Pfizer Inc. Janus Kinase inhibitors (JAKi) Product
 Table 79. Pfizer Inc. Recent Developments/Updates
 Table 80. AbbVie Company Information
 Table 81. AbbVie Description and Business Overview
 Table 82. AbbVie Janus Kinase inhibitors (JAKi) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. AbbVie Janus Kinase inhibitors (JAKi) Product
 Table 84. AbbVie Recent Developments/Updates
 Table 85. Galapagos NV Company Information
 Table 86. Galapagos NV Description and Business Overview
 Table 87. Galapagos NV Janus Kinase inhibitors (JAKi) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Galapagos NV Janus Kinase inhibitors (JAKi) Product
 Table 89. Galapagos NV Recent Developments/Updates
 Table 90. Key Raw Materials Lists
 Table 91. Raw Materials Key Suppliers Lists
 Table 92. Janus Kinase inhibitors (JAKi) Distributors List
 Table 93. Janus Kinase inhibitors (JAKi) Customers List
 Table 94. Janus Kinase inhibitors (JAKi) Market Trends
 Table 95. Janus Kinase inhibitors (JAKi) Market Drivers
 Table 96. Janus Kinase inhibitors (JAKi) Market Challenges
 Table 97. Janus Kinase inhibitors (JAKi) Market Restraints
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Janus Kinase inhibitors (JAKi)
 Figure 2. Global Janus Kinase inhibitors (JAKi) Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Janus Kinase inhibitors (JAKi) Market Share by Type: 2023 & 2030
 Figure 4. Tofacitinib Product Picture
 Figure 5. Abrocitinib Product Picture
 Figure 6. Baricitinib Product Picture
 Figure 7. Upadacitinib Product Picture
 Figure 8. Filgotinib Product Picture
 Figure 9. Global Janus Kinase inhibitors (JAKi) Market Value by Application (2024-2030) & (US$ Million)
 Figure 10. Global Janus Kinase inhibitors (JAKi) Market Share by Application: 2023 & 2030
 Figure 11. Hospital
 Figure 12. Clinic
 Figure 13. Other
 Figure 14. Global Janus Kinase inhibitors (JAKi) Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 15. Global Janus Kinase inhibitors (JAKi) Market Size (2019-2030) & (US$ Million)
 Figure 16. Global Janus Kinase inhibitors (JAKi) Sales (2019-2030) & (K Units)
 Figure 17. Global Janus Kinase inhibitors (JAKi) Average Price (US$/Unit) & (2019-2030)
 Figure 18. Janus Kinase inhibitors (JAKi) Report Years Considered
 Figure 19. Janus Kinase inhibitors (JAKi) Sales Share by Manufacturers in 2023
 Figure 20. Global Janus Kinase inhibitors (JAKi) Revenue Share by Manufacturers in 2023
 Figure 21. Global 5 and 10 Largest Janus Kinase inhibitors (JAKi) Players: Market Share by Revenue in Janus Kinase inhibitors (JAKi) in 2023
 Figure 22. Janus Kinase inhibitors (JAKi) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 23. Global Janus Kinase inhibitors (JAKi) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 24. North America Janus Kinase inhibitors (JAKi) Sales Market Share by Country (2019-2030)
 Figure 25. North America Janus Kinase inhibitors (JAKi) Revenue Market Share by Country (2019-2030)
 Figure 26. United States Janus Kinase inhibitors (JAKi) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. Canada Janus Kinase inhibitors (JAKi) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. Europe Janus Kinase inhibitors (JAKi) Sales Market Share by Country (2019-2030)
 Figure 29. Europe Janus Kinase inhibitors (JAKi) Revenue Market Share by Country (2019-2030)
 Figure 30. Germany Janus Kinase inhibitors (JAKi) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. France Janus Kinase inhibitors (JAKi) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. U.K. Janus Kinase inhibitors (JAKi) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Italy Janus Kinase inhibitors (JAKi) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Russia Janus Kinase inhibitors (JAKi) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Asia Pacific Janus Kinase inhibitors (JAKi) Sales Market Share by Region (2019-2030)
 Figure 36. Asia Pacific Janus Kinase inhibitors (JAKi) Revenue Market Share by Region (2019-2030)
 Figure 37. China Janus Kinase inhibitors (JAKi) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Japan Janus Kinase inhibitors (JAKi) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. South Korea Janus Kinase inhibitors (JAKi) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. India Janus Kinase inhibitors (JAKi) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Australia Janus Kinase inhibitors (JAKi) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. China Taiwan Janus Kinase inhibitors (JAKi) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Southeast Asia Janus Kinase inhibitors (JAKi) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Latin America Janus Kinase inhibitors (JAKi) Sales Market Share by Country (2019-2030)
 Figure 45. Mexico Janus Kinase inhibitors (JAKi) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Brazil Janus Kinase inhibitors (JAKi) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Argentina Janus Kinase inhibitors (JAKi) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Colombia Janus Kinase inhibitors (JAKi) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Middle East and Africa Janus Kinase inhibitors (JAKi) Sales Market Share by Country (2019-2030)
 Figure 50. Middle East and Africa Janus Kinase inhibitors (JAKi) Revenue Market Share by Country (2019-2030)
 Figure 51. Turkey Janus Kinase inhibitors (JAKi) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Saudi Arabia Janus Kinase inhibitors (JAKi) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. UAE Janus Kinase inhibitors (JAKi) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 54. Global Sales Market Share of Janus Kinase inhibitors (JAKi) by Type (2019-2030)
 Figure 55. Global Revenue Market Share of Janus Kinase inhibitors (JAKi) by Type (2019-2030)
 Figure 56. Global Janus Kinase inhibitors (JAKi) Price (US$/Unit) by Type (2019-2030)
 Figure 57. Global Sales Market Share of Janus Kinase inhibitors (JAKi) by Application (2019-2030)
 Figure 58. Global Revenue Market Share of Janus Kinase inhibitors (JAKi) by Application (2019-2030)
 Figure 59. Global Janus Kinase inhibitors (JAKi) Price (US$/Unit) by Application (2019-2030)
 Figure 60. Janus Kinase inhibitors (JAKi) Value Chain
 Figure 61. Janus Kinase inhibitors (JAKi) Production Process
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Janus Kinase Inhibitors Market Research Report 2024
Global Janus Kinase JAK Inhibitors Market Insights Forecast to 2030
JAK1 Inhibitor Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral JAK Inhibitors Market Research Report 2024
Global Janus Kinase JAK Inhibitor for for Alopecia Areata Market Research Report 2025
Oral JAK1 Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Janus Kinase Inhibitors for Alopecia Areata Market Research Report 2024
Tyrosine Kinase JAK Inhibitors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Small Molecule Targeted Drugs for Allergic Diseases Market Research Report 2024
Global Jakinibs Market Insights Forecast to 2030
Global Topical JAK Inhibitors Market Research Report 2024
Global TKIs for Breast Cancer Market Research Report 2024
Global Kinase Inhibitors For Cancer Treatment Market Research Report 2024
Global Single target MET TKIs Market Research Report 2024
Global Kinase Inhibitor in Autoimmune Diseases Market Research Report 2024
Global Ruxolitinib Drugs Market Research Report 2024
Global Tyrosine Kinase Inhibitors Market Research Report 2024
Global Multi target MET TKIs Market Research Report 2024
Global Janus Kinases Inhibitor Drugs Market Research Report 2024
Global TYK2 Targeting Drugs Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions